O'Shaughnessy Asset Management, LLC Biogen Inc. Transaction History

O'Shaughnessy Asset Management, LLC

$9.51 Billion
Q2 2024

A detailed history of O'Shaughnessy Asset Management, LLC transactions in Biogen Inc. stock. As of the latest transaction made, O'Shaughnessy Asset Management, LLC holds 4,832 shares of BIIB stock, worth $840,381. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,832

Previous 3,940 22.64%

Holding current value

$840,381

Previous $849,000 31.92%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$190.52 - $236.72 $169,943 - $211,154	892 Added 22.64%	4,832 $1.12 Million
Q1 2024 May 13, 2024	BUY	$212.02 - $267.71 $39,859 - $50,329	188 Added 5.01%	3,940 $849,000
Q4 2023 Feb 09, 2024	SELL	$222.59 - $267.94 $322,978 - $388,780	-1,451 Reduced 27.89%	3,752 $970,000
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $14,691 - $16,581	58 Added 1.13%	5,203 $1.34 Million
Q2 2023 Aug 11, 2023	BUY	$275.25 - $318.06 $68,537 - $79,196	249 Added 5.09%	5,145 $1.47 Million
Q1 2023 May 12, 2023	SELL	$256.56 - $292.34 $71,323 - $81,270	-278 Reduced 5.37%	4,896 $1.36 Million
Q4 2022 Feb 10, 2023	SELL	$252.44 - $306.72 $10.8 Million - $13.1 Million	-42,734 Reduced 89.2%	5,174 $1.43 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $5.26 Million - $7.25 Million	-27,024 Reduced 36.06%	47,908 $12.8 Million
Q2 2022 Aug 11, 2022	BUY	$187.54 - $223.02 $2.43 Million - $2.89 Million	12,938 Added 20.87%	74,932 $15.3 Million
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $3.94 Million - $4.96 Million	-20,318 Reduced 24.68%	61,994 $13.1 Million
Q4 2021 Feb 11, 2022	SELL	$223.92 - $287.77 $1.56 Million - $2.01 Million	-6,989 Reduced 7.83%	82,312 $19.7 Million
Q3 2021 Nov 10, 2021	SELL	$282.99 - $369.05 $1.21 Million - $1.58 Million	-4,291 Reduced 4.58%	89,301 $25.3 Million
Q2 2021 Aug 09, 2021	SELL	$259.0 - $414.71 $10.2 Million - $16.4 Million	-39,445 Reduced 29.65%	93,592 $32.4 Million
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $4.13 Million - $4.84 Million	-17,007 Reduced 11.33%	133,037 $37.2 Million
Q4 2020 Feb 11, 2021	SELL	$236.26 - $355.63 $18 Million - $27.1 Million	-76,081 Reduced 33.65%	150,044 $36.7 Million
Q3 2020 Nov 12, 2020	BUY	$264.77 - $305.71 $24.7 Million - $28.5 Million	93,321 Added 70.27%	226,125 $64.2 Million
Q2 2020 Aug 13, 2020	BUY	$258.66 - $342.55 $7.41 Million - $9.81 Million	28,631 Added 27.48%	132,804 $35.5 Million
Q1 2020 May 13, 2020	BUY	$268.85 - $341.04 $22.4 Million - $28.5 Million	83,432 Added 402.26%	104,173 $33 Million
Q4 2019 Feb 12, 2020	BUY	$220.06 - $304.07 $4.56 Million - $6.3 Million	20,734 Added 296200.0%	20,741 $6.15 Million
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $1,304 - $1,463	6 Added 600.0%	7 $2,000
Q2 2019 Aug 07, 2019	BUY	$219.29 - $241.72 $219 - $241	1 New	1 $0

Others Institutions Holding BIIB

# of Institutions

1,016

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.

Account

O'Shaughnessy Asset Management, LLC Biogen Inc. Transaction History